Humana Inc. (HUM) Comparison with companies in other sectors?

Humana Inc. has a share price of 120.69M. You can analyze Humana Inc. (HUM) competitors across different market sectors through stock heatmaps.

What are HUM's NET and operating margins?

Humana Inc. (HUM) operating margin is around 0.03, and net profit margin is approximately 0.01 as of the latest reports.

In what way does HUM's earnings per share (EPS) trend reflect its financial momentum?

Humana Inc. (HUM) EPS is 14.17 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for Humana Inc. is 16.80, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for Humana Inc.?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for Humana Inc. like P/E which is 16.70, P/B which is 1.61, and PEG which is 0.40. Compare them with sector averages to evaluate if the stock is priced fairly.

Humana Inc.

HUM•NYSE

Healthcare

Medical - Healthcare Plans

$237.98

$8.77(3.83%)

Fundamental Analysis of Humana Inc. (HUM)

Comprehensive financial metrics and ratios analysis

EPS (TTM)

$14.17

P/E Ratio

16.80

ROE

0.10%

Net Margin

0.01%

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$28.73B

Shares OutstandingTotal number of shares issued

$120.69M

Book Value/ShareNet worth per share

$147.99

Revenue/ShareAnnual revenue per share

$998.81

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$14.17

Net MarginNet income as percentage of revenue

1.42%

Operating MarginOperating income as percentage of revenue

2.78%

ROEReturn on shareholders' equity

10.006%

ROAReturn on total assets

3.36%

ROCEReturn on capital employed

10.16%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

$19.77

Cash/ShareCash and equivalents per share

$183.86

FCF YieldFree cash flow as percentage of market cap

8.34%

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

$3.54

Dividend YieldAnnual dividend as percentage of stock price

1.50%

Financial Ratios Analysis data is not available for HUMFinancial Ratios Analysis details for HUM are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for HUMSector Benchmarking details for HUM are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for Humana Inc. Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of Humana Inc.. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account Humana Inc.'s unique business strengths and challenges.

Key Financial Metrics for Humana Inc.

For Humana Inc., essential financial indicators include EPS 14.17, PE 16.80, and ROE 0.10. These key ratios reveal insights into Humana Inc.'s profitability, valuation, and operational health. Understanding these metrics enables you to compare Humana Inc. with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of Humana Inc.

Metrics like Net Margin 1.42% and ROA 3.36% shed light on how well Humana Inc. is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether Humana Inc. can sustain its operations and continue growing in the future.

Valuation and Market Position of Humana Inc.

Using ratios such as P/B Ratio 1.61 and PEG Ratio 0.40, investors can assess whether Humana Inc. is appropriately valued based on its financials and growth potential. These figures, combined with Humana Inc.'s market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for Humana Inc.

Financial health indicators, such as Debt/Equity Ratio 0.75 and Cash Flow $19.77, provide a snapshot of Humana Inc.'s ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like Humana Inc., is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for Humana Inc.

Investing in Humana Inc. based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at Humana Inc. focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;